Volume 7, Issue 5 pp. 309-312
Clinical Investigation

Radiation therapy for neurosarcoidosis: Report of three cases from a single institution

Song Kang M.D.

Song Kang M.D.

Cleveland Clinic Foundation, Department of Radiation Oncology, Cleveland, Ohio

Search for more papers by this author
John H. Suh M.D.

Corresponding Author

John H. Suh M.D.

Cleveland Clinic Foundation, Department of Radiation Oncology, Cleveland, Ohio

Cleveland Clinic Foundation, Department of Radiation Oncology, 9500 Euclid Avenue, T28, Cleveland, OH 44195Search for more papers by this author

Abstract

Sarcoidosis is a chronic, multisystemic disorder of unknown etiology. The incidence of central nervous system involvement is as high as 5%. Although steroids have been the cardinal treatment for sarcoidosis, many patients become symptomatically unresponsive to them. Other patients may suffer from glucose intolerance, cataracts, and obesity, which are adverse effects of high-dose steroids. Various reports in the literature suggest that some chemotherapeutic agents and/or radiation may be useful in these situations. We present three patients with neurosarcoidosis who were treated with radiation at a single institution. We also review previous reports on radiation-treated neurosarcoid patients. While the results vary, some patients clearly derive symptomatic benefits from low-dose radiation. Since the side effects of low-dose cranial irradiation are minimal, it may be prudent to use radiation therapy for patients who are refractory to steroids or who suffer adversely from high-dose steroids. Radiat. Oncol. Invest. 7:309–312, 1999. © 1999 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.